` CRVL (CorVel Corp) vs S&P 500 Comparison - Alpha Spread

CRVL
vs
S&P 500

Over the past 12 months, CRVL has outperformed S&P 500, delivering a return of 23% compared to the S&P 500's 10% growth.

Stocks Performance
CRVL vs S&P 500

Loading
CRVL
S&P 500
Add Stock

Performance Gap
CRVL vs S&P 500

Loading
CRVL
S&P 500
Difference
www.alphaspread.com

Performance By Year
CRVL vs S&P 500

Loading
CRVL
S&P 500
Add Stock

Competitors Performance
CorVel Corp vs Peers

CorVel Corp
Glance View

Economic Moat
None
Market Cap
5.2B USD
Industry
Health Care

In the intricate world of healthcare management, CorVel Corporation stands as a pivotal player, harmonizing technology and service to streamline the complexities of risk management and cost containment. Founded in 1987, CorVel has relentlessly pursued the mission of enhancing workplace injury claims processes, reducing expenses while ensuring quality care for the injured. The company's foundation is built on its ability to provide innovative solutions through advanced technology platforms that automate and optimize the management of workers’ compensation, liability claims, and healthcare services. By integrating data analytics, artificial intelligence, and cutting-edge claims management software, CorVel enables employers, insurers, and third-party administrators to keep a tight rein on costs and improve outcomes through proactive decision-making and efficient service delivery. CorVel’s revenue model is intricately tied to its suite of diversified services. The company generates income through its extensive offerings in network solutions, bill review, case management, and pharmacy benefit management. Network solutions form the backbone, providing clients with access to a broad network of medical providers while negotiating favorable rates. Meanwhile, their robust bill review system ensures that every medical claim is scrutinized for accuracy and compliance, a process that helps clients avoid overpayments and recover funds. Case management services further augment their revenue, as skilled professionals facilitate rehabilitation efforts, coordinate care, and monitor recovery progress to encourage cost savings. Moreover, the pharmacy benefit management branch secures additional profit by optimizing prescription costs and improving medication adherence. Together, these services create a seamless ecosystem where CorVel captures significant value through efficiency gains and cost control, solidifying its position in the competitive healthcare management landscape.

CRVL Intrinsic Value
44.35 USD
Overvaluation 56%
Intrinsic Value
Price
Back to Top